Shuffler News
Parkinsons and Dopamine Agonists, a story !
The words of someone who has been to hell and back and still climbing out of it.
“Agonists are like your best friend acting nice, but in the bigger picture they have an alterior motive far more sinister than any benefit that the friendship could ever provide.
For most it works, but my experience was stomach churningly horrendous, with life long repucussions of the highest order, loss of business, reputation, family houses, economic and social supports.
Structured social and medical supports, as well as paitent suitability given patient personailty and lifestyle, are required that extend way beyond what the medical profession currently offers .
These supports need to look for and continually monitor for the hidden signals, behaviour changes, reclusiveness, adverse risk taking, clouded judgement, as the participant can very easily deliberately hide the obvious signs of compulsive behaviour, which may seem trivial to those looking in, but will rock the foundations for the person who sought the benefit, ripping their insides with decay and leaving a shell of a human with nothing left inside.”
There is a moral duty of care that isn’t being acknowledged, and those affected are too proud to publicly admit that they fell prey to the fiery forks of the devil disguised.
This could never happen to me, I won’t be judged by my friends so I’ll keep it to myself”
Stories from Agonist Survivors
Parkinsons: Dopamine Agonists. Dangers !
3-Month Boxing Program Found to Ease Motor, Non-Motor Symptoms
A tailored three-month boxing exercise program significantly eased both motor and non-motor symptoms — including depression, anxiety, sleep problems, and pain — in people with early Parkinson’s disease, a new study shows. While the program’s
Butyrate Made by Gut Bacteria Linked to Depression
Among people with Parkinson’s disease, lower levels of a bacterial compound called butyrate in the gut are associated with more severe depression, a new study indicates. Results also revealed that altered butyrate levels in Parkinson’s
Exercises for Trunk Rigidity Seen to Help Patients Safely Make Turns
A four-week, task-specific exercise program done at home can improve turning ability and balance, and ease disease severity for people with early- to mid-stage Parkinson’s, a small study suggested. This Parkinson’s exercise program focuses explicitly
Fujirebio Bolsters Its Parkinson’s Diagnostic Tools With Acquisition
Fujirebio Holdings’ portfolio of biomarkers and diagnostic tools for Parkinson’s disease now includes tailor-made antibodies against the protein alpha-synuclein with the company’s acquisition of ADx NeuroSciences. The $40 million acquisition is expected to be complete in
The Resilience of Spring, My Garden, and Life With Parkinson’s
Resilience is the single best predictor of success in life and in building sanctuary. When you live in a tornado-prone area, building a garden sanctuary can be risky. Spring is the time to revitalize from
Impaired Heart Rate Function Linked to Dementia in 5-Year Study
Impairment due to Parkinson’s disease of the involuntary nervous system, which controls heart rate, among other bodily functions, was associated with worse outcomes after five years — particularly relative to dementia, daily motor activities, and quality
New LRRK2 Gene Mutations Linked With Familial Parkinson′s
Two new mutations in the LRRK2 gene have been identified as likely causes of familial Parkinson’s disease, a study reports. Further studies on these potential “disease-causing variants should help us to better understand how LRRK2 dysfunction
Redefining Victory Moments as My Parkinson’s Progresses
Living with Parkinson’s disease can feel like an insurmountable challenge. As we strive to maintain our mobility and preserve our way of life, we look for ways to empower ourselves as patients. We want to
Mania After DBS Tied to Stimulating Specific Brain Regions, Study Finds
Among people with Parkinson’s undergoing deep brain stimulation (DBS), those who receive stimulation in a certain brain region — the medial and ventral subthalmic nucleus — are more likely to develop a distressing side effect
Denali’s DNL201 Safely Engages Target Enzyme: Multiple Studies
Denali Therapeutics‘ DNL201, an investigational therapy for Parkinson’s disease, was well tolerated in healthy volunteers and patients, and showed evidence of engaging its target protein, according to multiple preclinical and clinical studies. LRRK2, a protein
Posts from the author
Shufflernews
Parkinsons
Subscribe
Phone
0490 33 22 68
shuffles@shufflenews.com